T

The University of Toledo | University of Toledo Medical Center - Rheumatology and Immunology Department

Research site

(Unclaimed)

Location

3000 Arlington Ave., Toledo, Ohio, United States of America

Site insights

Top conditions

Top treatments

Bupivacaine

OKN-007

BPS-314d-MR-PAH-303

YKP3089

Indacaterol

Temozolomide

TTX-080

Relugolix

UT-15C

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

Open-label Study Investigating of OKN-007 Combined with Temozolomide in Patients with Recurrent Glioblastoma

This is a phase II open-label study investigating the efficacy, safety and pharmacokinetic(PK) properties of OKN-007 combined with temozolomide(TMZ)...

Active, not recruiting

Brain Glioblastoma

Recurrent Malignant Glioma

Drug: Temozolomide (TMZ)

Drug: OKN-007

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...

Active, not recruiting

Cancer

Drug: cetuximab

Drug: TTX-080